McKesson revenue increased from $214.3 billion in 2019 to $231.1 billion in 2020, a (7.8%) increase.

Annual Revenue ($)

McKesson revenue was $231.05 b in FY, 2020 which is a (7.8%) year over year increase from the previous period.

Quarterly Revenue ($)

FY, 2018FY, 2019FY, 2020
Revenue$208.36 b$214.32 b$231.05 b
Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021
Revenue$52.61 b$53.08 b$56.21 b$55.73 b$57.62 b$59.17 b$55.68 b$60.81 b$62.6 b

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Geographic Segment

McKesson revenue breakdown by business segment: 79.4% from U.S. Pharmaceutical and Specialty Solutions, 11.9% from European Pharmaceutical Solutions, 5.2% from Other and 3.6% from Other

McKesson revenue breakdown by geographic segment: 16.6% from Foreign and 83.4% from United States

FY, 2020FY, 2019FY, 2018
Other $12.02 b$11.7 b$11.84 b
Medical-Surgical Solutions$8.31 b$7.62 b$6.61 b
U.S. Pharmaceutical and Specialty Solutions$183.34 b$167.76 b$162.59 b
European Pharmaceutical Solutions$27.39 b$27.24 b$27.32 b
Distribution Solutions$208.12 b
Technology Solutions$240 m
FY, 2020FY, 2019FY, 2018
United States$192.71 b$176.3 b$169.94 b
Foreign$38.34 b$38.02 b$38.41 b

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu